Trilogy Capital Inc. Increases Stock Holdings in Veeva Systems Inc. (NYSE:VEEV)

Trilogy Capital Inc. raised its position in shares of Veeva Systems Inc. (NYSE:VEEV) by 26.0% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 9,202 shares of the technology company’s stock after purchasing an additional 1,896 shares during the period. Trilogy Capital Inc.’s holdings in Veeva Systems were worth $1,935,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Confluence Wealth Services Inc. lifted its position in Veeva Systems by 7.2% during the fourth quarter. Confluence Wealth Services Inc. now owns 1,069 shares of the technology company’s stock valued at $238,000 after buying an additional 72 shares during the period. Lion Street Advisors LLC lifted its position in Veeva Systems by 10.3% during the fourth quarter. Lion Street Advisors LLC now owns 2,489 shares of the technology company’s stock valued at $523,000 after buying an additional 232 shares during the period. Old North State Wealth Management LLC lifted its position in Veeva Systems by 0.4% during the fourth quarter. Old North State Wealth Management LLC now owns 15,351 shares of the technology company’s stock valued at $3,228,000 after buying an additional 55 shares during the period. E. Ohman J or Asset Management AB lifted its position in Veeva Systems by 5.6% during the fourth quarter. E. Ohman J or Asset Management AB now owns 185,987 shares of the technology company’s stock valued at $39,104,000 after buying an additional 9,800 shares during the period. Finally, Boston Trust Walden Corp purchased a new position in Veeva Systems during the fourth quarter valued at $7,964,000. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Insider Activity

In other news, SVP Jonathan Faddis sold 1,694 shares of Veeva Systems stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $230.30, for a total transaction of $390,128.20. Following the transaction, the senior vice president now directly owns 8,061 shares of the company’s stock, valued at $1,856,448.30. The trade was a 17.37 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 10.50% of the company’s stock.

Veeva Systems Stock Down 0.1 %

Veeva Systems stock opened at $239.09 on Friday. The business has a 50-day simple moving average of $224.05 and a two-hundred day simple moving average of $213.83. The company has a market cap of $38.82 billion, a P/E ratio of 59.04, a P/E/G ratio of 2.05 and a beta of 0.85. Veeva Systems Inc. has a 52-week low of $170.25 and a 52-week high of $258.93.

Analyst Ratings Changes

Several equities analysts have commented on VEEV shares. Scotiabank raised their price objective on Veeva Systems from $235.00 to $240.00 and gave the company a “sector perform” rating in a research report on Friday, December 6th. KeyCorp lowered their price target on Veeva Systems from $285.00 to $255.00 and set an “overweight” rating for the company in a research report on Wednesday, January 8th. StockNews.com lowered Veeva Systems from a “buy” rating to a “hold” rating in a research report on Thursday. Royal Bank of Canada lifted their price target on Veeva Systems from $275.00 to $285.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $270.00 price target on shares of Veeva Systems in a research report on Friday, January 17th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and seventeen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $253.96.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.